Krilogy Financial LLC Puma Biotechnology, Inc. Transaction History

Krilogy Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $4,014 - $9,340	-200 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$41.2 - $59.85 $8,240 - $11,970	200 New	200 $9,000
Q2 2018 Aug 15, 2018	SELL	$48.3 - $68.25 $9,660 - $13,650	-200 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$59.7 - $99.25 $5,970 - $9,925	100 Added 100.0%	200 $14,000
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $9,385 - $13,244	100	100 $10,000

101

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $137M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.